Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR 3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes

International Immunology

Volumn 16, Issue 1, 2004, Pages 55-63

  Fujimoto, Chiaki ^a   Nakagawa, Yohko ^a   Ohara, Kunitoshi ^a   Takahashi, Hidemi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cytotoxic T lymphocyte; Dendritic cell; HIV 1; Poly(I:C); Toll like receptor

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; INFLUENZA VIRUS HEMAGGLUTININ; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; POLYINOSINIC POLYCYTIDYLIC ACID; RECOMBINANT GLYCOPROTEIN GP 120; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL CULTURE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; VIRION; VIRUS REPLICATION;

ANIMALS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV; HIV ENVELOPE PROTEIN GP120; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; POLYNUCLEOTIDES; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 0346098026     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh025     Document Type: Article

References (48)

1. Fearon, D. T. and Locksley, R. M. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50.
2. Kaisho, T. and Akira, S. 2002. Toll-like receptors as adjuvant receptors. Biochim. Biophys. Acta 1589:1.
3. Medzhitov, R. and Janeway, C., Jr. 2000. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173:89.
4. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K. and Akira, S. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740,
5. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B. and Beutler, B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.
6. Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K. and Akira, S. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443.
7. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M. and Kirschning, C. J. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274:17406.
8. Takeuchi, J., Watari, E., Shinya, E., Norose, Y., Matsumoto, M., Seya, T., Sugita, M., Kawana, S. and Takahashi, H. 2003. Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in the epidermal Langerhans cells. Biochem. Biophys. Res. Commun. 306:674.
9. Alexopoulou, L., Holt, A. C., Medzhitov, R. and Flavell, R. A. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll- like receptor 3. Nature 413:732.
10. Bendelac, A. and Medzhitov, R. 2002. Adjuvants of immunity: harnessing innate immunity to promote adaptive immunity. J. Exp. Med. 195:F19.
11. Takahashi, H., Cohen, J., Hosmalin, A., Cease, K. B., Houghten, R., Comette, J. L., DeLisi, C., Moss, B., Germain, R. N. and Berzofsky, J. A. 1988. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl Acad. Sci. USA 85:3105.
12. Javaherian, K., Langlois, A. J., McDanal, C., Ross, K. L., Eckler, L. I., Jellis, C. L., Profy, A. T., Rusche, J. R., Bolognesi, D. P., Putney, S. D., et al. 1989. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl Acad. Sci. USA 86:6768.
13. Tamura, M., Kuwano, K., Kurane, I. and Ennis, F. A. 1998. Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1-specific, H-2-specific, and H1- and H2-cross-reactive murine cytotoxic T-lymphocyte clones. J. Virol. 72:9404.
14. Ceredig, R., Lowenthal, J. W., Nabholz, M. and MacDonald, H. R. 1985. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature 314:98.
15. Sarmiento, M., Glasebrook, A. L. and Fitch, F. W. 1980. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol. 125:2665.
16. Takahashi, H., Houghten, R., Putney, S. D., Margulies, D. H., Moss, B., Germain, R. N. and Berzofsky, J. A. 1989. Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein. J. Exp. Med. 170:2023.
17. d mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer. J. Immunol. 130:463.
18. d recombinants. J. Exp. Med. 166:327.
19. Takahashi, H., Cease, K. B. and Berzofsky, J. A. 1989. Identification of proteases that process distinct epitopes on the same protein. J. Immunol. 142:2221.
20. Chakrabarti, S., Robert-Guroff, M., Wong-Staal, F., Gallo, R. C. and Moss, B. 1986. Expression of the HTLV-III envelope gene by a recombinant vaccinia virus. Nature 320:535.
21. + HIV-1 envelope-specific murine CTL by short exposure to antigenic pepticle. J. Immunol. 169:6588.
22. Inaba, K., Inaba, M., Naito, M. and Steinman, R. M. 1993. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178:479.
23. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
24. h cells. J. Exp. Med. 177:1199.
25. De Smedt, T., Van Mechelen, M., De Becker, G., Urbain, J., Leo, O. and Moser, M. 1997. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27:1229.
26. H1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10. J. Immunol. 167:1423.
27. + cytotoxic T lymphocytes. Eur. J. Immunol. 26:2595.
28. Meegan, J. M. and Marcus, P. I. 1989. Double-stranded ribonuclease coinduced with interferon. Science 244:1089.
29. Horner, A. A., Datta, S. K., Takabayashi, K., Belyakov, I. M., Hayashi, T., Cinman, N., Nguyen, M. D., Van Uden, J. H., Berzofsky, J. A., Richman, D. D. and Raz, E. 2001. Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites. J. Immunol. 167:1584.
30. Maurer, T., Heit, A., Hochrein, H., Ampenberger, F., O'Keeffe, M., Bauer, S., Lipford, G. B., Vabulas, R. M. and Wagner, H. 2002. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells. Eur. J. Immunol. 32:2356.
31. Takahashi, H., Nakagawa, Y., Yokomuro, K. and Berzofsky, J. A. 1993. Induction of CD84 cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int. Immunol. 5:849.
32. Verhasselt, V., Buelens, C., Willems, F., De Groote, D., Haeffner-Cavaillon, N. and Goldman, M. 1997. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J. ImmunoL 158:2919.
33. Kakugawa, K., Udaka, K., Nakashima, K., Inaba, K., Oka, Y., Sugiyama, H., Tamamura, H. and Yamagishi, H. 2000. Efficient induction of peptide-specific cytotoxic T lymphocytes by LPS-activated spleen cells. Microbiol. Immunol. 44:123.
34. + T cells in vitro, whereas CD40 ligation is essential. J. Immunol. 167:6247.
35. Verdijk, R. M., Mutis, T., Esendam, B., Kamp, J., Melief, C. J., Brand, A. and Goulmy, E. 1999. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J. Immunol. 163:57.
36. Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I. and Lanzavecchia, A. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:821.
37. Corradin, G., Etlinger, H. M. and Chiller, J. M. 1977. Lymphocyte specificity to protein antigens. I. Characterization of the antigen-induced in vitro T cell-dependent proliferative response with lymph node cells from primed mice. J. Immunol. 119:1048.
38. Ahlers, J. D., Dunlop, N., Ailing, D. W., Nara, P. L. and Berzofsky, J. A. 1997. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes. J. Immunol. 158:3947.
39. Maitre, N., Brown, J. M., Demcheva, M., Kelley, J. R., Lockett, M. A., Vournakis, J. and Cole, D. J. 1999. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination. Clin. Cancer. Res. 5:1173.
40. + cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 344:873.
41. Hussain, L. A. and Lehner, T. 1995. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 85:475.
42. Lin, C. L., Sewell, A. K., Gao, G. F., Whelan, K. T., Phillips, R. E. and Austyn, J. M. 2000. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis. J. Exp. Med. 192:587.
43. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245.
44. Takahashi, H. 1993. Antigen processing and presentation. Microbiol. Immunol. 37:1.
45. Takahashi, H. 2003. Antigen presentation in vaccine development. Comp. Immunol. Microbiol. Infect. Dis. 26:309.
46. Datta, S. K., Redecke, V., Prilliman, K. R., Takabayashi, K., Corr, M., Tallant, T., DiDonato, J., Dziarski, R., Akira, S., Schoenberger, S. P. and Raz, E. 2003. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J. Immunol. 170:4102.
47. Salazar-Onfray, F., Charo, J., Petersson, M., Freland, S., Noffz, G., Qin, Z., Blankenstein, T., Ljunggren, H. G. and Kiessling, R. 1997. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10. J. Immunol. 159:3195.
48. Petersson, M., Charo, J., Salazar-Onfray, F., Noffz, G., Mohaupt, M., Qin, Z., Klein, G., Blankenstein, T. and Kiessling, R. 1998. Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1. J. Immunol. 161:2099.